Biomedical Engineering Reference
In-Depth Information
4. Petropoulou Chryssoula, MD, PhD, Paediatrician-Neonatologist
5. Manolidou Zaharoula, R.N., M.Sc, Colonel rt (M.C.), National Health
Operations Centre, General Coordinator - Ministry of Health, Greece.
6. Tseroni Maria, RN, M.A. in Health and Social Care Management, National
Health Operations Centre, Coordinator - Ministry of Health, Greece.
7. Gogosis konstantinos, RN, ENA, M.Sc., National Health Operations Centre,
Director - Ministry of Health, Greece.
8. Logothetis Emmanuel, M.D., Medical School of the Athens University,
Areteion Hospital Microbiology Lab.
9. Tsouma I., MD, Medical School of the Athens University, Areteion Hospital
Microbiology Lab.
10. Efstathiou Andreas, MD
11. Karyoti Vassiliki, M.Sc. Geologist - Geoenvironmentalist
12. Agrafa Ioanna, BA - National Health Operations Centre, Administrator, -
Ministry of Health, Greece.
13. Efstathiou Elina, B.Sc. - Physiotherapist.
14. Karyotis Marios, Statistician - Actuary
References
1. Barie PS, Ho VP (2012) The value of critical care. Surg Clin North Am 92(6):1445-1462
2. Borkow G, Gabbay J (2005) Copper as a biocidal tool. Curr Med Chem 12(18):2163-2175
3. Bozkurt F, Kaya S, Tekin R, Gulsun S, Deveci O, Dayan S, Ho¸oglu S (2014) Analysis
of antimicrobial consumption and cost in a teaching hospital. J Infect Public Health.
7(2):161-169. doi:
10.1016/j.jiph.2013.09.007
4. Deane RS, Mills EL, Hamel AJ (1970) Antimicrobial action of copper in respiratory therapy
apparatus. Chest 58(4):373-377
5. Efstathiou P, Anagnostakou M, Kouskouni E, Petropoulou C, Karageorgou K, Manolidou Z,
Papanikolaou S, Tseroni M, Logothetis E, Karyoti V (2013) Implementation of antimicrobial
copper in neonatal intensive care unit. Antimicrob Resist Infect Control 2(Suppl 1):O68
6. Efstathiou P, Kouskouni E, Papanikolaou S, Karageorgou K, Manolidou Z, Tseroni M,
Logothetis E, Petropoulou C, Karyoti V (2013) Financial benefits after the implementation
of antimicrobial copper in intensive care units (ICUs). Antimicrob Resist Infect Control
2(Suppl 1):369
7. Efstathiou P, Kouskouni E, Papanikolaou S, Karageorgou K, Manolidou Z, Tseroni M,
Logothetis E, Agrafa I (2013) Copper alloys beneficial effects on ICU Operation. In: Interna-
tional meeting on emerging diseases and surveillance (IMED), Vienna, Austria
8. Efstathiou P, Kouskouni E, Papanikolaou S, Karageorgou K, Manolidou Z, Tseroni M,
Logothetis E (2012) Reducing Hcais with simple interventions using Copper alloys: improving
outcomes in a time of austerity. In: 12th Congress of the International Federation of Infection
Control (IFIC), Zagreb, Croatia, 10-13 Oct 2012
9. Efstathiou P, Kouskouni E, Tseroni M, Manolidou Z, Karageorgou K, Logothetis E, Tsuma H,
Patikas H, Agrafa I (2013) Antimicrobial copper (cu +) implementation and its influence to the
epidemiological data in elementary school population. In: Poster presentation, 31st annual
meeting of the European Society of Paediatric Infectious Diseases (ESPID), Milan, Italy
10. Efstathiou PA (2011) The role of antimicrobial copper surfaces in reducing healthcare
associated infections. Eur Infect Dis 5(2):125-128
Search WWH ::
Custom Search